Related Experiment Video
Updated: May 10, 2026

A High Throughput Screen for Biomining Cellulase Activity from Metagenomic Libraries
Published on: February 1, 2011
A Facile Method for Screening DPP IV Inhibitors in Living Cell System Based on Enzyme Activity Probe.
Shu-Mei Pan1, Chun-Yu Xing1, Hong-Wei Li2
1Collaborative Innovation Center of Tumor Marker Detection Technology, Equipment and Diagnosis Therapy Integration in Universities of Shandong, Shandong Province Key Laboratory of Detection Technology for Tumor Makers, School of Chemistry and Chemical Engineering, Linyi University, Linyi 276005, China.
Researchers developed a user-friendly assay to measure dipeptidyl peptidase IV (DPP IV) activity in live cells. This tool enables sensitive detection of DPP IV function and efficient screening of potential DPP IV inhibitors for metabolic diseases.
Area of Science:
- Biochemistry
- Enzymology
- Cellular Biology
Background:
- Dipeptidyl peptidase IV (DPP IV) is a crucial enzyme involved in cellular metabolism and signaling.
- DPP IV plays a role in both normal physiological and pathological processes, particularly metabolic diseases.
- Targeting DPP IV is essential for developing treatments for metabolic disorders.
Purpose of the Study:
- To develop a simple, sensitive, and selective assay for human DPP IV activity in live cells.
- To enable efficient screening of DPP IV inhibitors.
- To facilitate understanding of DPP IV's role in disease.
Main Methods:
- Established a cell-based fluorescence assay using a specific DPP IV fluorescent probe.
- Optimized experimental conditions including cell density, probe concentration, and incubation time.
- Validated the assay by evaluating the efficacy of known DPP IV inhibitors.
Main Results:
- Developed a user-friendly, high-throughput assay for cellular DPP IV activity.
- The assay demonstrated good precision, robustness, and reliability.
- Successfully used the assay to evaluate DPP IV inhibitor efficacy.
Conclusions:
- A straightforward and reliable method for detecting DPP IV activity in live cells has been established.
- This assay facilitates accurate assessment of DPP IV function and efficient inhibitor screening.
- The method has potential implications for understanding DPP IV in disease, early diagnosis, and personalized therapy.

